Drug · DIN 02085895
DILAUDID
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 7, 2013; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02085895
- Company (DIN owner)
- Purdue PharmaToronto, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Powder For Solution
- Route
- Intravenous; Intramuscular; Subcutaneous
- Therapeutic class (ATC)
- Hydromorphone N02AA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE | 250 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 8, 2008: NOC 9711New Drug Submission (NDS) · Manufacturer name change
- July 19, 2001: NOC 2308New Drug Submission (NDS) · Cahnge in manufacturer's name
- May 9, 1994: NOC 5702Supplement to a New Drug Submission (SNDS) · New dosage form
Other DINs named DILAUDID
- DIN 00125083 · Marketed
- DIN 00125121 · Marketed
- DIN 00705438 · Marketed
- DIN 00786543 · Marketed
- DIN 00125105 · Cancelled Post Market
- DIN 00627100 · Cancelled Post Market
- DIN 00786535 · Cancelled Post Market